CervoMed Inc.
CRVO
$4.09
-$0.15-3.54%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 4.01M | 6.16M | 7.78M | 9.31M | 9.74M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 4.01M | 6.16M | 7.78M | 9.31M | 9.74M |
| Cost of Revenue | 21.82M | 23.07M | 22.16M | 20.82M | 18.80M |
| Gross Profit | -17.81M | -16.91M | -14.38M | -11.51M | -9.06M |
| SG&A Expenses | 10.48M | 10.29M | 10.18M | 9.42M | 9.17M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 32.30M | 33.36M | 32.33M | 30.24M | 27.97M |
| Operating Income | -28.29M | -27.20M | -24.56M | -20.94M | -18.23M |
| Income Before Tax | -26.97M | -25.58M | -22.61M | -18.67M | -16.29M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -26.97 | -25.58 | -22.61 | -18.67 | -16.29 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -26.97M | -25.58M | -22.61M | -18.67M | -16.29M |
| EBIT | -28.29M | -27.20M | -24.56M | -20.94M | -18.23M |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -2.97 | -2.87 | -2.58 | -2.14 | -1.99 |
| Normalized Basic EPS | -1.86 | -1.79 | -1.61 | -1.34 | -1.24 |
| EPS Diluted | -2.97 | -2.87 | -2.58 | -2.14 | -1.99 |
| Normalized Diluted EPS | -1.86 | -1.79 | -1.61 | -1.34 | -1.24 |
| Average Basic Shares Outstanding | 36.16M | 35.61M | 35.06M | 34.82M | 32.28M |
| Average Diluted Shares Outstanding | 36.16M | 35.61M | 35.06M | 34.82M | 32.28M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |